Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.

SZSE:300937 Stock Report

Market Cap: CN¥2.9b

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical has a total shareholder equity of CN¥845.7M and total debt of CN¥269.1M, which brings its debt-to-equity ratio to 31.8%. Its total assets and total liabilities are CN¥1.7B and CN¥849.1M respectively. Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's EBIT is CN¥23.9M making its interest coverage ratio 4.2. It has cash and short-term investments of CN¥266.7M.

Key information

31.8%

Debt to equity ratio

CN¥269.08m

Debt

Interest coverage ratio4.2x
CashCN¥266.67m
EquityCN¥845.73m
Total liabilitiesCN¥849.06m
Total assetsCN¥1.69b

Recent financial health updates

No updates

Recent updates

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Nov 12
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd.'s (SZSE:300937) P/S Is Still On The Mark Following 48% Share Price Bounce

Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Sep 27
Capital Allocation Trends At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Aren't Ideal

Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture

Jun 07
Returns On Capital At Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937) Paint A Concerning Picture

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Apr 17
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical's (SZSE:300937) Earnings Are Of Questionable Quality

Financial Position Analysis

Short Term Liabilities: 300937's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥815.8M).

Long Term Liabilities: 300937's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥33.2M).


Debt to Equity History and Analysis

Debt Level: 300937's net debt to equity ratio (0.3%) is considered satisfactory.

Reducing Debt: 300937's debt to equity ratio has increased from 9% to 31.8% over the past 5 years.

Debt Coverage: 300937's debt is not well covered by operating cash flow (19.2%).

Interest Coverage: 300937's interest payments on its debt are well covered by EBIT (4.2x coverage).


Balance Sheet


Discover healthy companies